SCHEMBL5264084

SCHEMBL5264084

CCOC(=O)OC1CCN(c2ncnc(Nc3ccc4c(c3)OCO4)c2[N+](=O)[O-])CC1

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 18/20 0.57
PRMT1 Q99873 1/20 0.49
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264918 0.94 GPR119 (0.56) GPR119PRMT1
SCHEMBL389293 0.90 GPR119 (0.71) GPR119PRMT1
SCHEMBL5260816 0.89 GPR119 (0.55) GPR119
SCHEMBL5260172 0.86 GPR119 (0.65) GPR119
SCHEMBL5264940 0.85 GPR119 (0.64) GPR119
SCHEMBL5264420 0.84 GPR119 (0.57) GPR119
SCHEMBL5264569 0.84 GPR119 (0.57) GPR119
SCHEMBL5260975 0.84 GPR119 (0.80) GPR119
SCHEMBL5263198 0.84 GPR119 (0.57) GPR119
SCHEMBL5263545 0.84 GPR119 (0.57) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599468-B1 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA ARENA PHARM INC (US) 2007-10-03 EP claimed